AmSurg rated a ‘Buy’

By Walker Duncan Posted on July 6, 2009 at 11:39 am

TheStreet.com Ratings announced early this morning that it has upgraded surgery center operator AmSurg to “Buy”

The numbers: Fiscal first-quarter revenue rose 12% to $163 million as net income climbed 7.8% to $13 million and earnings per share ascended 8.1% to 40 cents, extending a growth streak to nine quarters. The cash balance is ample with $31 million of reserves. The debt-to-equity ratio is low at 0.6. The net margin is wide at 7.7% but has shed 30 basis points since last year’s first quarter.

The stock: Amsurg is down 10% in 2009, trading at a price-to-earnings ratio of about 13. The company has a market capitalization of $670 million.

permalink

Tags: Ambulatory surgery centers, AmSurg Corp., Health Care, Public companies, TheStreet.com  

Comments